Potentially exciting new regarding the @Oxford #COVIDVaccine
- Similar immune response in older and younger adults
- Adverse responses to vaccine in elderly were lower
- Provides protection for about 1 yearhttps://t.co/pbmO43zoix

— Krutika Kuppalli, MD FIDSA (@KrutikaKuppalli) October 26, 2020